KRISTEN BEST-FRIESZ: Open Payments
NPI 1427610658 · SCHENECKEDY, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,150 in 91 payments from 16 companies in 2025. Trend: 2023 $2,815 · 2024 $1,968 · 2025 $2,150
Food & beverage: $2,095Education: $55
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 26 | $490 |
| GlaxoSmithKline, LLC. | 13 | $298 |
| Regeneron Healthcare Solutions, Inc. | 7 | $228 |
| HARMONY BIOSCIENCES LLC | 6 | $208 |
| Amgen Inc. | 8 | $176 |
| GENZYME CORPORATION | 4 | $140 |
| ABBVIE INC. | 6 | $125 |
| Insmed, Inc. | 6 | $121 |
| Verona Pharma, Inc. | 3 | $94 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 3 | $71 |
Products named: TEZSPIRE, DUPIXENT, NUCALA, WAKIX, Arikayce, FASENRA, AIRSUPRA, Ohtuvayre.
Industry payments across NY — which companies pay providers there.
